USSTOCK.TODAY
Regular Market
Log in Sign up

Argenx continues growth with strong cash flow and pipeline

The Motley Fool +1 · ·by G4L

ARGX Argen X SE ADR
$962.27 +3.78%
View chart & analysis →
  1. 1Argenx stock has recorded a 180% increase since early 2022.
  2. 2Third-quarter revenue reached $1.7 billion, a 54% increase from the previous year.
  3. 3Argenx aims for 60,000 treatable patients by 2030.

So what's the key point?

Argenx increased its revenue by 54% compared to last year and is earning money well. The company plans to continue growing by treating more patients in the future.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Argenx SE to Acquire Unnatural Products for Approximately $1.15 Billion Investing.com +1 · yesterdayArgenx shares fall as Q3 operating profit misses consensus Investing.com +2 · Oct 22Argenx shares plunge 16% on discontinuation of Sjögren's syndrome treatment trial Investing.com +8 · Oct 8
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news